S.F. finds a taker for Mission Bay office space Oct 4, 2009
A growing South Bay biotech company scored a cheap lease, and the city of San Francisco got a new business as part of a deal revealed Friday in which Nektar Therapeutics Inc. will take over Mission Bay office space recently abandoned by drug giant Pfizer. Images. (San Francisco Chronicle)
Nektar Presents Data Demonstrating Favorable Oral Bioavailability and Drug-Drug Interaction Profile for NKTR-118 Sep 14, 2009
Sept. 13 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: ) presented clinical study data today demonstrating that the oral tablet formulation of NKTR-118 has favorable systemic bioavailability and a low risk for mediating significant drug-drug interactions ... Nektar Therapeutics is a biopharmaceutical company developing novel therapeutics based on its PEGylation and advanced polymer conjugation technology platforms ... For more information on Nektar Therapeutics, please visit. (PR Newswire)
Nektar narrows Q2 loss to $32.1M Aug 5, 2009
Nektar Therapeutics narrows Q2 loss to $32 ... Nektar Therapeutics narrows Q2 loss to $32. (San Jose Business Journal, CA)
Nektar to Announce Financial Results for the First Quarter of 2009 on Wednesday, May 6, 2009, After Close of U.S.-Based Financial Markets Apr 30, 2009
April 29 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: ) will announce its financial results for the first quarter ended March 31, 2009 on Wednesday, May 6, 2009, after the close of U.S.-based financial markets ... Nektar Therapeutics is a biopharmaceutical company developing novel therapeutics based on its advanced polymer conjugation technology platforms ... Jennifer Ruddock, 650-631-4954, Nektar Therapeutics. (PR Newswire)
Nektar Therapeutics Reports Fourth Quarter and Year-End 2008 Financial Results Feb 25, 2009
Feb. 24 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: ) today reported its financial results for the fourth quarter and year ended December 31, 2008 ... Nektar Therapeutics is a biopharmaceutical company developing novel therapeutics based on its PEGylation and advanced polymer conjugate technology platforms ... For more information on Nektar Therapeutics, please visit. (PR Newswire)
Weekly business calendar Feb 23, 2009
-- Earnings reports expected from Aruba Networks, Del Monte Foods, Limited Brands, Nektar Therapeutics, OpenTV, Saks, Salesforce. com, TJX.. (San Francisco Chronicle -- Business)
Novartis/Nestle may see cycle of negotiations over Alcon option rights in 4Q 2009 Feb 11, 2009
Last year, Novartis made a number of bolt-on acquisitions, including Protez Pharmaceuticals, Nektar Therapeutics and the remaining stake in Speedel Holding. In a recent SEC filing, Novartis reported that as of 31 December 2008 it had cash, short-term deposits and marketable securities of USD 6. (FT.com -- Markets)
